STOCK TITAN
  1. Home
  2. ETTX

Entasis Therapeutics Holdings (ETTX) Stock Price, News & Analysis

ETTX NASDAQ

Company Description

Entasis Therapeutics Holdings (NASDAQ: ETTX) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for ETTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
47.9M
Shares outstanding

Latest News

View All
—

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022

-0.45%

Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.

-0.46%

Entasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conference

+21.11%

Innoviva to Acquire Entasis Therapeutics

acquisition
+21.11%

Innoviva to Acquire Entasis Therapeutics

acquisition
+1.14%

Entasis Therapeutics Presents Data Highlights from Phase 3 ATTACK Trial at 2022 American Thoracic Society Annual Conference

clinical trial

Entasis Therapeutics Holdings has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, clinical trial, earnings. View all ETTX news →

SEC Filings

View All

No SEC filings available for ETTX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ETTX Company Profile & Sector Positioning

Entasis Therapeutics Holdings (ETTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.